Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
10.1200/JCO.20.02060
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
AMER SOC CLINICAL ONCOLOGY
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-229088 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2290882023-10-31T08:17:58Z Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial Dimopoulos, Meletios A Spicka, Ivan Quach, Hang Oriol, Albert Hajek, Roman Garg, Mamta Beksac, Meral Bringhen, Sara Katodritou, Eirini Chng, Wee-Joo Leleu, Xavier Iida, Shinsuke Mateos, Maria-Victoria Morgan, Gareth Vorog, Alexander Labotka, Richard Wang, Bingxia Palumbo, Antonio Lonial, Sagar DEAN'S OFFICE (MEDICINE) Science & Technology Life Sciences & Biomedicine Oncology CONTINUOUS THERAPY PLUS LENALIDOMIDE FIXED DURATION DOUBLE-BLIND OPEN-LABEL BORTEZOMIB DEXAMETHASONE OUTCOMES DARATUMUMAB PREDNISONE 10.1200/JCO.20.02060 JOURNAL OF CLINICAL ONCOLOGY 38 34 2022-07-24T04:23:44Z 2022-07-24T04:23:44Z 2020-12-01 2022-07-17T12:07:41Z Article Dimopoulos, Meletios A, Spicka, Ivan, Quach, Hang, Oriol, Albert, Hajek, Roman, Garg, Mamta, Beksac, Meral, Bringhen, Sara, Katodritou, Eirini, Chng, Wee-Joo, Leleu, Xavier, Iida, Shinsuke, Mateos, Maria-Victoria, Morgan, Gareth, Vorog, Alexander, Labotka, Richard, Wang, Bingxia, Palumbo, Antonio, Lonial, Sagar (2020-12-01). Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial. JOURNAL OF CLINICAL ONCOLOGY 38 (34). ScholarBank@NUS Repository. https://doi.org/10.1200/JCO.20.02060 0732183X 15277755 https://scholarbank.nus.edu.sg/handle/10635/229088 en AMER SOC CLINICAL ONCOLOGY Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Oncology CONTINUOUS THERAPY PLUS LENALIDOMIDE FIXED DURATION DOUBLE-BLIND OPEN-LABEL BORTEZOMIB DEXAMETHASONE OUTCOMES DARATUMUMAB PREDNISONE |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Oncology CONTINUOUS THERAPY PLUS LENALIDOMIDE FIXED DURATION DOUBLE-BLIND OPEN-LABEL BORTEZOMIB DEXAMETHASONE OUTCOMES DARATUMUMAB PREDNISONE Dimopoulos, Meletios A Spicka, Ivan Quach, Hang Oriol, Albert Hajek, Roman Garg, Mamta Beksac, Meral Bringhen, Sara Katodritou, Eirini Chng, Wee-Joo Leleu, Xavier Iida, Shinsuke Mateos, Maria-Victoria Morgan, Gareth Vorog, Alexander Labotka, Richard Wang, Bingxia Palumbo, Antonio Lonial, Sagar Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial |
| description |
10.1200/JCO.20.02060 |
| author2 |
DEAN'S OFFICE (MEDICINE) |
| author_facet |
DEAN'S OFFICE (MEDICINE) Dimopoulos, Meletios A Spicka, Ivan Quach, Hang Oriol, Albert Hajek, Roman Garg, Mamta Beksac, Meral Bringhen, Sara Katodritou, Eirini Chng, Wee-Joo Leleu, Xavier Iida, Shinsuke Mateos, Maria-Victoria Morgan, Gareth Vorog, Alexander Labotka, Richard Wang, Bingxia Palumbo, Antonio Lonial, Sagar |
| format |
Article |
| author |
Dimopoulos, Meletios A Spicka, Ivan Quach, Hang Oriol, Albert Hajek, Roman Garg, Mamta Beksac, Meral Bringhen, Sara Katodritou, Eirini Chng, Wee-Joo Leleu, Xavier Iida, Shinsuke Mateos, Maria-Victoria Morgan, Gareth Vorog, Alexander Labotka, Richard Wang, Bingxia Palumbo, Antonio Lonial, Sagar |
| author_sort |
Dimopoulos, Meletios A |
| title |
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial |
| title_short |
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial |
| title_full |
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial |
| title_fullStr |
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial |
| title_full_unstemmed |
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial |
| title_sort |
ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation: the phase iii tourmaline-mm4 trial |
| publisher |
AMER SOC CLINICAL ONCOLOGY |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/229088 |
| _version_ |
1781793157083561984 |